Potential for improvement of docetaxel-based chemotherapy: a pharmacological review

por Engels, F K, Sparreboom, A, Mathot, R A A, Verweij, J
Publicado 2005

Determinants of drug absorption in different ECMO circuits

por Wildschut, E. D., Ahsman, M. J., Allegaert, K., Mathot, R. A. A., Tibboel, D.
Publicado 2010

Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR

por de Vries, E. M., Lammers, L. A., Achterbergh, R., Klümpen, H-J, Mathot, R. A. A., Boelen, A., Romijn, J. A.
Publicado 2016

In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients

por Preijers, T., van Spengler, M. W. F., Meijer, K., Fijnvandraat, K., Fischer, K., Leebeek, F. W. G., Cnossen, M. H., Mathôt, R. A. A.
Publicado 2021

Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation

por Wildschut, E. D., Hanekamp, M. N., Vet, N. J., Houmes, R. J., Ahsman, M. J., Mathot, R. A. A., de Wildt, S. N., Tibboel, D.
Publicado 2010

Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients

por Hodiamont, C J, Juffermans, N P, Berends, S E, van Vessem, D J, Hakkens, N, Mathôt, R A A, de Jong, M D, van Hest, R M
Publicado 2021

Population pharmacokinetics of haloperidol in terminally ill adult patients

por Franken, L. G., Mathot, R. A. A., Masman, A. D., Baar, F. P. M., Tibboel, D., van Gelder, T., Koch, B. C. P., de Winter, B. C. M.
Publicado 2017

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks

por Kerbusch, T, Groenewegen, G, Mathôt, R A A, Herben, V M M, ten Bokkel Huinink, W W, Swart, M, Ambaum, B, Rosing, H, Jansen, S, Voest, E E, Beijnen, J H, Schellens, J H M
Publicado 2004

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

por van Rhee, K P, de Vroom, S L, van Hest, R M, van der Linden, P D, Tonino, S H, Molendijk, E, Mathôt, R A A, Blijlevens, N M A, Knibbe, C A J, Bruggemann, R J M, Geerlings, S E
Publicado 2022

The role of plasma concentrations and drug characteristics of beta‐blockers in fall risk of older persons

por Ploegmakers, K. J., van Poelgeest, E. P., Seppala, L. J., van Dijk, S. C., de Groot, L. C. P. G. M., Oliai Araghi, S., van Schoor, N. M., Stricker, B., Swart, K. M. A., Uitterlinden, A. G., Mathôt, R. A. A., van der Velde, N.
Publicado 2023

Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users?

por Pronk, A. C., van Poelgeest, E. P., Seppala, L. J., Ploegmakers, K. J., Stricker, B. H., Swart, K. M. A., van Dijk, S. C., Oliai Araghi, S., de Groot, L. C. P. G. M., van Schoor, N. M., Mathôt, R. A. A., van der Velde, N.
Publicado 2023

Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling

por Janssen, Alexander, Hoogendoorn, Mark, Cnossen, Marjon H., Mathôt, Ron A. A., Cnossen, M. H., Reitsma, S. H., Leebeek, F. W. G., Mathôt, R. A. A., Fijnvandraat, K., Coppens, M., Meijer, K., Schols, S. E. M., Eikenboom, H. C. J., Schutgens, R. E. G., Beckers, E. A. M., Ypma, P., Kruip, M. J. H. A., Polinder, S., Tamminga, R. Y. J., Brons, P., Fischer, K., van Galen, K. P. M., Heubel‐Moenen, F. C. J. I., Nieuwenhuizen, L., Driessens, M. H. E., van Vliet, I., Lock, J., Hazendonk, H. C. A. M., van Moort, I., Heijdra, J. M., Goedhart, M. H. J., Al Arashi, W., Preijers, T., de Jager, N. C. B., Bukkems, L. H., Cloesmeijer, M. E., Janssen, A., Collins, P. W., Liesner, R., Chowdary, P., Millar, C. M., Hart, D., Keeling, D.
Publicado 2022